TMCnet News

Agere CEO to Present Innovations in Formulating for Oral Bioavailability
[September 04, 2014]

Agere CEO to Present Innovations in Formulating for Oral Bioavailability


BEND, Ore. --(Business Wire)--

Agere Pharmaceuticals, Inc., a leading innovator in oral bioavailability solutions and specializing in amorphous solid dispersions announced today that it will present at the Catalent interactive training session this month in Somerset, New Jersey. The agenda features other renowned experts including those from Catalent Pharma Solutions, St. John's University and the University of Mississippi.

CONFERENCE: Advances in Drug Delivery - Optimal Bioavailability and Controlled Release for Improved Outcomes

When: Wednesday, September 10th, 2014 (8:30 AM - 4:30 PM)

Where: The Palace, Somerset, NJ

Agenda & Free Registration: Please follow the link to the event page



For more information about this event or to schedule a meeting with Agere, please contact Agere at [email protected].

About Agere


Agere is a leading CDMO focused on improving the oral bioavailability of insoluble active pharmaceutical ingredients (APIs). The company supports clients from screening to identify the optimal solubilization technology, formulation design and development, and cGMP manufacturing for Phase I through Phase IIb clinical trial materials. All services follow industry best practices guidelines, and are delivered on a fee-for-service basis. Agere's proprietary formulation design platform, Quadrant 2™, enables the company to deliver a customized solution for every compound to serve each individual client's requirements. The company is located in Bend, OR. For information: www.agerepharma.com.

For more details, visit www.drugdeliveryinstitute.com.

Agere Pharmaceuticals and Quadrant 2 are trademarks owned by Agere Pharmaceuticals, Inc.


[ Back To TMCnet.com's Homepage ]